These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3002297)

  • 1. Degranulation inhibition. A potential mechanism for control of neutrophil superoxide production in sepsis.
    Solomkin JS; Brodt JK; Zemlan FP
    Arch Surg; 1986 Jan; 121(1):77-80. PubMed ID: 3002297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
    Fletcher MP; Stahl GL; Longhurst JC
    J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-induced expression of cryptic receptors on the neutrophil surface: a mechanism for regulation of acute inflammation in trauma.
    Solomkin JS; Cotta LA; Ogle JD; Brodt JK; Ogle CK; Satoh PS; Hurst JM; Alexander JW
    Surgery; 1984 Aug; 96(2):336-44. PubMed ID: 6087484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of neutrophil superoxide production in sepsis.
    Solomkin JS; Cotta LA; Brodt JK; Hurst JM
    Arch Surg; 1985 Jan; 120(1):93-8. PubMed ID: 2981524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.
    Feltner DE; Smith RH; Marasco WA
    J Immunol; 1986 Sep; 137(6):1961-70. PubMed ID: 3018082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R; Elfman F; Perez HD
    J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of two arachidonate 5-lipoxygenase inhibitors on formyl-methionyl-leucyl-phenylalanine (fMLP) and complement fragment 5a induced human neutrophil superoxide generation.
    Kocan GP; Partis RA; Mueller RA; Smith WG; Nakao A
    Biochem Pharmacol; 1994 Mar; 47(6):1029-37. PubMed ID: 8147901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity.
    Kaufmann I; Hoelzl A; Schliephake F; Hummel T; Chouker A; Peter K; Thiel M
    Shock; 2006 Sep; 26(3):254-61. PubMed ID: 16912650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K; Grünbaum L; Seifert R
    J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human C5a modulates monocyte Fc and C3 receptor expression.
    Yancey KB; O'Shea J; Chused T; Brown E; Takahashi T; Frank MM; Lawley TJ
    J Immunol; 1985 Jul; 135(1):465-70. PubMed ID: 3158706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner.
    Suda T; Suzuki Y; Matsui T; Inoue T; Niide O; Yoshimaru T; Suzuki H; Ra C; Ochiai T
    Br J Dermatol; 2005 May; 152(5):887-95. PubMed ID: 15888142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effect of rebamipide on gastric mucosal cell damage evoked by activation of formyl-methionyl-leucyl-phenylalanine receptors of rabbit neutrophils.
    Kim CD; Hong KW
    J Pharmacol Exp Ther; 1997 Apr; 281(1):478-83. PubMed ID: 9103534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of superoxide production in human neutrophils by combinations of heparin and thrombolytic agents.
    Riesenberg K; Schlaeffer F; Katz A; Levy R
    Br Heart J; 1995 Jan; 73(1):14-9. PubMed ID: 7888254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
    J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.